FDA Approvals - Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track
Neurologix Gene Therapy Approach to Parkinson's Disease Granted Fast Track Designation From FDA (Business Wire via Yahoo! Finance)
FORT LEE, N.J.----Neurologix, Inc. , a biotech company engaged in the research and development of innovative gene therapies for the brain and central nervous system, announced today that the U.S.
Lannett Receives FDA Approval for Phentermine (Business Wire via Yahoo! Finance)
PHILADELPHIA----Lannett Company, Inc. today announced it has received approval from the U.S. Food and Drug Administration for the company's supplemental Abbreviated New Drug Application of Phentermine Hydrochloride Capsules 30 mg.